Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
PTC Therapeutics Inc (NASDAQ: PTCT) closed the day trading at $40.65 down -18.62% from the previous closing price of $49.95. In other words, the price has decreased by -$18.62 from its previous closing price. On the day, 4.2 million shares were traded.
Ratios:
For a better understanding of PTCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on March 11, 2025, Upgraded its rating to Neutral and sets its target price to $55 from $41 previously.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $55.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 13, 2024, whereas the target price for the stock was revised from $45 to $67.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 22 ’25 when Klein Matthew B. sold 2,804 shares for $48.74 per share. The transaction valued at 136,656 led to the insider holds 273,234 shares of the business.
Klein Matthew B. bought 2,804 shares of PTCT for $136,656 on Apr 22 ’25. On Apr 02 ’25, another insider, Golden Lee Scott, who serves as the EVP & CHIEF MEDICAL OFFICER of the company, sold 897 shares for $46.95 each. As a result, the insider received 42,114 and left with 75,997 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.97.
Stock Price History:
Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $28.72. The 50-Day Moving Average of the stock is -19.07%, while the 200-Day Moving Average is calculated to be -5.50%.
Shares Statistics:
A total of 77.70M shares are outstanding, with a floating share count of 76.82M. Insiders hold about 2.60% of the company’s shares, while institutions hold 97.39% stake in the company.